| Cannabis-based medicines in multiple sclerosis--a review of clinical studies. | |
| | |
MedLine Citation:
|
PMID: 20541836 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
For some years a mixture of anecdotal report and data from animal models have implied a potential role for cannabis-based medicines in ameliorating a variety of symptoms of multiple sclerosis. Only recently however have large randomised controlled trials (RCTs) examined these potential effects rigorously. At present the results of RCTs have lacked a coherent message to the prescribing clinician and reasons for such heterogeneity in cannabinoid trials are discussed. |
| | |
Authors:
|
David J Rog |
Related Documents
:
|
7768246 - Emea and the new pharmaceutical procedures for europe. european medicines evaluation ag... 19019546 - Do stocking rate and a simple run management practice influence the infection of laying... 15012396 - Ecology and management of hazelnut pests. 7983616 - Locus of control, machiavellianism, and managerial job performance. 11985176 - The causes and management of foot ulceration. 21487396 - Effective weight management practice: a review of the lifestyle intervention evidence. |
Publication Detail:
|
Type: Journal Article; Review Date: 2010-04-07 |
Journal Detail:
|
Title: Immunobiology Volume: 215 ISSN: 1878-3279 ISO Abbreviation: Immunobiology Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-15 Completed Date: 2010-10-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8002742 Medline TA: Immunobiology Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 658-72 Citation Subset: IM |
Copyright Information:
|
2010 Elsevier GmbH. All rights reserved. |
Affiliation:
|
Greater Manchester Neurosciences Centre, Stott Lane, Manchester M68HD, UK. David.Rog@srft.nhs.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cannabinoids
/
therapeutic use* Cannabis* Humans Multiple Sclerosis / drug therapy* Phytotherapy* Randomized Controlled Trials as Topic |
| Chemical | |
Reg. No./Substance:
|
0/Cannabinoids |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: On the link between contaminant source release conditions and plume prediction uncertainty.
Next Document: Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease.